Matt Larew
Stock Analyst at William Blair
(4.84)
# 407
Out of 5,044 analysts
231
Total ratings
63.8%
Success rate
28.5%
Average return
Main Sectors:
Stocks Rated by Matt Larew
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Reiterated: Hold | n/a | $16.35 | - | 3 | Oct 6, 2026 | |
| OPCH Option Care Health | Reiterated: Buy | n/a | $31.07 | - | 14 | Oct 6, 2026 | |
| RVTY Revvity | Initiated Coverage: Buy | n/a | $154.18 | - | 1 | Oct 5, 2026 | |
| TKNO Alpha Teknova | Reiterated: Buy | n/a | $8.84 | - | 10 | Sep 30, 2026 | |
| TXG 10x Genomics | Reiterated: Buy | n/a | $80.65 | - | 11 | Sep 29, 2026 | |
| AVTR Avantor | Reiterated: Hold | n/a | $15.67 | - | 10 | Sep 21, 2026 | |
| VCYT Veracyte | Reiterated: Buy | n/a | $45.23 | - | 2 | Sep 15, 2026 | |
| GH Guardant Health | Reiterated: Buy | n/a | $167.47 | - | 5 | Sep 8, 2026 | |
| QGEN Qiagen | Rated: Hold | n/a | $45.38 | - | 3 | Aug 24, 2026 | |
| SERA Sera Prognostics | Reiterated: Buy | n/a | $2.04 | - | 2 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.5897 | - | 1 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $72.46 | - | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.05 | - | 14 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.44 | - | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $400.71 | - | 1 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.02 | - | 1 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $98.09 | - | 1 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.40 | - | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $433.77 | - | 6 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $63.67 | - | 2 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $159.78 | - | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $120.38 | - | 13 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $70.93 | - | 2 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.49 | - | 1 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $173.88 | - | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $658.02 | - | 11 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $366.00 | - | 12 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $219.81 | - | 9 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.01 | - | 10 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $13.00 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $301.79 | n/a | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $84.67 | n/a | 4 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.15 | n/a | 1 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.10 | n/a | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | - | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $179.25 | n/a | 4 | Sep 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $312.15 | n/a | 1 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $123.33 | n/a | 1 | Nov 21, 2017 |
NeoGenomics
Oct 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $16.35
Upside: -
Option Care Health
Oct 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.07
Upside: -
Revvity
Oct 5, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $154.18
Upside: -
Alpha Teknova
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.84
Upside: -
10x Genomics
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $80.65
Upside: -
Avantor
Sep 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $15.67
Upside: -
Veracyte
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $45.23
Upside: -
Guardant Health
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $167.47
Upside: -
Qiagen
Aug 24, 2026
Rated: Hold
Price Target: n/a
Current: $45.38
Upside: -
Sera Prognostics
Aug 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.04
Upside: -
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.5897
Upside: -
Aug 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $72.46
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.05
Upside: -
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.44
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $400.71
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.02
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $98.09
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.40
Upside: -
Aug 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $433.77
Upside: -
Aug 3, 2026
Rated: Hold
Price Target: n/a
Current: $63.67
Upside: -
Aug 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $159.78
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $120.38
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $70.93
Upside: -
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.49
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $173.88
Upside: -
Jul 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $658.02
Upside: -
Jul 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $366.00
Upside: -
Jul 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $219.81
Upside: -
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $1.01
Upside: -
May 11, 2026
Reiterated: Sell
Price Target: n/a
Current: $13.00
Upside: -
Oct 11, 2025
Upgraded: Buy
Price Target: n/a
Current: $301.79
Upside: n/a
Oct 8, 2024
Reiterated: Hold
Price Target: n/a
Current: $84.67
Upside: n/a
Aug 22, 2022
Reiterated: Buy
Price Target: n/a
Current: $14.15
Upside: n/a
Sep 22, 2021
Downgraded: Hold
Price Target: n/a
Current: $9.10
Upside: n/a
Aug 4, 2021
Downgraded: Hold
Price Target: n/a
Current: -
Upside: n/a
Sep 11, 2019
Downgraded: Hold
Price Target: n/a
Current: $179.25
Upside: n/a
Dec 3, 2018
Reiterated: Buy
Price Target: n/a
Current: $312.15
Upside: n/a
Nov 21, 2017
Initiated Coverage: Buy
Price Target: n/a
Current: $123.33
Upside: n/a